Scholarlink

<p>Consumer sleep technology (CST) has an emerging role in monitoring sleep, including screening or surveillance of sleep disorders; however, few data are available on CST in patients with obstructive sleep apnea. We analyzed attitudes toward CST and patterns of CST use among individuals with obstructive sleep apnea. Among 251 respondents (mean age 57.5 years; 58.2% female), 66.5% reported CST use, and 92.0% indicated that monitoring obstructive sleep apnea treatment response would be a useful feature of CST. Individuals with a household income &lt; $30,000 (odds ratio 0.26; <i>P</i> = .008) or identifying as a minority/other race (odds ratio 0.15; <i>P</i> = .021) were less likely to use CST. Older age (beta coefficient 0.05; <i>P</i> &lt; .001), Medicare insurance (beta coefficient 1.26; <i>P</i> = .006), and positive airway pressure use (beta coefficient 1.79; <i>P</i> = .008) were associated with increased nights/wk of CST use. These findings demonstrate a high perceived value of CST for monitoring treatment response among individuals with obstructive sleep apnea but disparate use by sociodemographic and clinical factors.</p> Citation: <p>Lenze NR, Kazemi RJ, Ikeda AK, et&#xa0;al. Consumer sleep technology use in individuals with obstructive sleep apnea: does it have a role in monitoring treatment response? <i>J Clin Sleep Med.</i> 2025;21(3):593–597.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Consumer sleep technology use in individuals with obstructive sleep apnea: does it have a role in monitoring treatment response?

  • 期刊论文

  • 发表日期：

    2025年3月1日

查看全文
  • Nicholas R. Lenze,
  • Ruby J. Kazemi,
  • Allison K. Ikeda,
  • Punithavathy Vijayakumar,
  • Cathy A. Goldstein,
  • Jeffrey J. Stanley,
  • Michael J. Brenner,
  • Paul T. Hoff

摘要

Consumer sleep technology (CST) has an emerging role in monitoring sleep, including screening or surveillance of sleep disorders; however, few data are available on CST in patients with obstructive sleep apnea. We analyzed attitudes toward CST and patterns of CST use among individuals with obstructive sleep apnea. Among 251 respondents (mean age 57.5 years; 58.2% female), 66.5% reported CST use, and 92.0% indicated that monitoring obstructive sleep apnea treatment response would be a useful feature of CST. Individuals with a household income < $30,000 (odds ratio 0.26; P = .008) or identifying as a minority/other race (odds ratio 0.15; P = .021) were less likely to use CST. Older age (beta coefficient 0.05; P < .001), Medicare insurance (beta coefficient 1.26; P = .006), and positive airway pressure use (beta coefficient 1.79; P = .008) were associated with increased nights/wk of CST use. These findings demonstrate a high perceived value of CST for monitoring treatment response among individuals with obstructive sleep apnea but disparate use by sociodemographic and clinical factors.

Citation:

Lenze NR, Kazemi RJ, Ikeda AK, et al. Consumer sleep technology use in individuals with obstructive sleep apnea: does it have a role in monitoring treatment response? J Clin Sleep Med. 2025;21(3):593–597.